We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$211M
AUM Growth
-$33.6M
Cap. Flow
-$28.2M
Cap. Flow %
-13.35%
Top 10 Hldgs %
69.11%
Holding
65
New
7
Increased
7
Reduced
12
Closed
9

Top Buys

Rank Stock Value
1
CFLT
Confluent
CFLT
+$1.51M
2
MMD
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
+$710K
3
MO icon
Altria Group
MO
+$587K
4
AMPL icon
Amplitude
AMPL
+$268K
5
MRK icon
Merck
MRK
+$206K

Top Sells

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$11.5M
2
ABCL icon
AbCellera Biologics
ABCL
+$5.8M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.47M
4
AMZN icon
Amazon
AMZN
+$3.35M
5
META icon
Meta Platforms (Facebook)
META
+$2.67M

Sector Composition

Rank Sector Weight
1 Communication Services 28%
2 Consumer Discretionary 17.49%
3 Energy 16.44%
4 Healthcare 12.22%
5 Technology 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
51
Merck
MRK
$318B
$226K 0.11%
+2,020
New +$206K
V icon
52
Visa
V
$677B
$208K 0.1%
+1,000
New +$202K
S icon
53
SentinelOne
S
$7.34B
$180K 0.09%
12,322
– –
DNA icon
54
Ginkgo Bioworks
DNA
$521M
$52.7K 0.03%
+780
New +$71.7K
DM
55
DELISTED
Desktop Metal, Inc.
DM
$44.5K 0.02%
3,270
-800
-20% -$16.7K
BLND icon
56
Blend Labs
BLND
$386M
$27.6K 0.01%
+19,154
New +$34.3K
ATXS
57
DELISTED
Astria Therapeutics
ATXS
– –
-24,331
Closed -$220K
BTI icon
58
British American Tobacco
BTI
$128B
– –
-18,686
Closed -$677K
GOOG icon
59
Alphabet (Google) Class C
GOOG
$4.32T
– –
-3,100
Closed -$298K
IOVA icon
60
Iovance Biotherapeutics
IOVA
$2.87B
– –
-92,500
Closed -$886K
MMM icon
61
3M
MMM
$94.3B
– –
-3,588
Closed -$332K
VBIV
62
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-2,167
Closed -$46K
LABP
63
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
– –
-12,726
Closed -$83K
ZY
64
DELISTED
Zymergen Inc. Common Stock
ZY
– –
-34,000
Closed -$95K
GBT
65
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-168,725
Closed -$11.5M
1 2
3

Similar funds

CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
CWAF
Core Wealth Advisors (Florida) Lakeland, Florida $419M AUM 16.86% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return
PIMC
Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return
VIS
Vega Investment Solutions Paris, France $418M AUM

ArchPoint Investors's Q4 2022 Portfolio in Review

As of Q4 2022, ArchPoint Investors held 65 positions worth $211M, down 14% from $245M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ArchPoint Investors withdrew a net $28.2M in Q4 2022, closing 9 positions and reducing 12 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $11.5M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, ArchPoint Investors opened a new position in Confluent worth $1.45M.

  • ArchPoint Investors's largest Q4 2022 buy was Confluent: 65,184 shares worth $1.45M.
  • ArchPoint Investors added most to Altria Group in Q4 2022, an estimated $587K increase.
  • ArchPoint Investors's biggest Q4 2022 reduction was AbCellera Biologics, cutting an estimated $5.8M.
  • ArchPoint Investors fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $11.5M.
  • ArchPoint Investors's ten largest holdings make up 69% of its $211M portfolio in Q4 2022.
  • ArchPoint Investors opened 7 new positions and closed 9 in Q4 2022.
  • ArchPoint Investors's portfolio value fell 14% quarter-over-quarter to $211M.

Based on ArchPoint Investors's 13F filing for Q4 2022, filed 13 Feb 2023.